​

LAVA Therapeutics Ownership | Who Owns LAVA Therapeutics?

OverviewForecastRevenueFinancialsChart

LAVA Therapeutics Ownership Summary

LAVA Therapeutics is owned by 24.11% institutional investors, 36.02% insiders, and 39.87% retail investors. Redmile group is the largest institutional shareholder, holding 7.73% of LVTX shares. Bruce is the top mutual fund, with 2.94% of its assets in LAVA Therapeutics shares.

LVTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockLAVA Therapeutics24.11%36.02%39.87%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Redmile group2.07M7.73%$1.97M
Sanofi1.92M7.15%$1.83M
Merck1.15M4.28%$1.09M
Bruce771.87K2.88%$733.28K
Sphera funds management126.33K0.47%$120.14K
Pathway financial advisors102.50K0.38%$97.48K
Pnc financial services group65.00K0.24%$61.81K
Two sigma investments, lp48.77K0.18%$46.38K
Bnp paribas arbitrage, snc41.80K0.16%$39.75K
Engineers gate manager lp31.98K0.12%$30.42K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sanofi1.92M1.05%$1.83M
Merck1.15M0.42%$1.09M
Bruce771.87K0.24%$733.28K
Redmile group2.07M0.14%$1.97M
Pathway financial advisors102.50K0.02%$97.48K
Sphera funds management126.33K0.02%$120.14K
Two sigma securities13.16K0.00%$12.51K
Virtu financial19.92K0.00%$19.00K
Engineers gate manager lp31.98K0.00%$30.42K
Hrt financial lp17.84K0.00%$16.00K

Top Buyers

HolderShares% AssetsChange
Sanofi1.92M1.05%1.92M
Merck1.15M0.42%1.15M
Bnp paribas arbitrage, snc41.80K-41.80K
Engineers gate manager lp31.98K0.00%20.09K
Hrt financial lp17.84K0.00%17.84K

Top Sellers

HolderShares% AssetsChange
Alpha wave global, lp---87.40K
Two sigma investments, lp48.77K0.00%-53.99K
Tang capital management---53.10K
Susquehanna group, llp---48.20K
Xtx topco---30.81K

New Positions

HolderShares% AssetsChangeValue
Sanofi1.92M1.05%1.92M$1.83M
Merck1.15M0.42%1.15M$1.09M
Bnp paribas arbitrage, snc41.80K-41.80K$39.75K
Hrt financial lp17.84K0.00%17.84K$16.00K
Two sigma securities13.16K0.00%13.16K$12.51K

Sold Out

HolderChange
Tsfg-400.00
Simplex trading-2.59K
Walleye capital-14.76K
Schonfeld strategic advisors-18.30K
Two sigma advisers, lp-26.90K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202421-8.70%6,472,86779.38%2413.32%13116.67%3-57.14%
Sep 30, 2024239.52%3,608,399-3.99%136.84%6-33.33%7133.33%
Jun 30, 202421-8.70%3,758,209-0.08%147.11%9-30.77%3-
Mar 31, 20242364.29%3,761,071-35.55%142.85%13225.00%3-25.00%
Dec 31, 202314-5,835,4382.05%224.69%4300.00%4100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Bruce771.87K2.94%-
Evli Hannibal156.83K0.60%-
Mutual Fund Evli Hannibal156.83K0.60%-
Mandarine Global Microcap G EUR27.50K0.10%-
Fidelity Nasdaq Composite Index16.16K0.06%-

Insider Transactions Trends

DateBuySell
2025 Q1--

LVTX Ownership FAQ

Who Owns LAVA Therapeutics?

LAVA Therapeutics shareholders are primarily institutional investors at 24.11%, followed by 36.02% insiders and 39.87% retail investors. The average institutional ownership in LAVA Therapeutics's industry, Biotech Stocks , is 68.48%, which LAVA Therapeutics falls below.

Who owns the most shares of LAVA Therapeutics?

LAVA Therapeutics’s largest shareholders are Redmile group (2.07M shares, 7.73%), Sanofi (1.92M shares, 7.15%), and Merck (1.15M shares, 4.28%). Together, they hold 19.16% of LAVA Therapeutics’s total shares outstanding.

Does Blackrock own LAVA Therapeutics?

BlackRock is not among the top 10 institutional shareholders of LAVA Therapeutics.

Who is LAVA Therapeutics’s biggest shareholder by percentage of total assets invested?

Sanofi is LAVA Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.05% of its assets in 1.92M LAVA Therapeutics shares, valued at 1.83M$.

Who is the top mutual fund holder of LAVA Therapeutics shares?

Bruce is the top mutual fund holder of LAVA Therapeutics shares, with 2.94% of its total shares outstanding invested in 771.87K LAVA Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools